David Sinclair Harvard Medical School, USA
David A. Sinclair, Ph.D. is best known for his work on understanding why we age and how to slow its effects. He is a tenured Professor of Genetics at Harvard Medical School, co-Director of the Paul F. Glenn Laboratories for the Biological Mechanisms of Aging at Harvard Medical School, a Professor at the University of New South Wales, Sydney, and an Honorary Professor at the University of Sydney. He received his Ph.D. from the University of New South Wales (1995), did his postdoctoral work at M.I.T. in Boston (1995-1999). He was recruited to Harvard Medical School and shortly thereafter became founding Director of the Paul F. Glenn Center for Aging Research, a group that has grown into a consortium of 11 universities and more than 500 scientists. He has published 130 papers and is an inventor on 28 patents. He has co-founded ten biotechnology companies in the areas of aging, vaccines, diabetes/cancer, biodefense, forensics and bioinformatics. He serves as co-chief editor of the scientific journal Aging, is an inventor on 35 patents and has received more than 25 awards and honors including the CSL Prize, The Australian Commonwealth Prize, Thompson Prize, Helen Hay Whitney Postdoctoral Award, Charles Hood Fellowship, Leukemia Society Fellowship, Ludwig Scholarship, Harvard-Armenise Fellowship, American Association for Aging Research Fellowship, Nathan Shock Award from the National Institutes of Health, Ellison Medical Foundation Junior and Senior Scholar Awards, Merck Prize, Genzyme Outstanding Achievement in Biomedical Science Award, Bio-Innovator Award, David Murdock-Dole Lectureship, Fisher Honorary Lectureship, Les Lazarus Lectureship, Australian Medical Research Medal, The Frontiers in Aging and Regeneration Award, Top 100 Australian Innovators, and TIME magazine’s list of the “100 most influential people in the world."
